WELCOME: All men and their partners, who are newly diagnosed and researching treatments, men under treatment, those previously treated, those who are experiencing a recurrence, and those who have advanced or metatstatic prostate cancer.
Men and Women living in the Washington DC Metro area & around the US, please join the Loudoun County Us TOO Prostate Cancer Education and Support Group, sponsored by Inova Life with Cancer, on ZOOM on the second Tuesday of every month from 6:30 – 8:30 pm. ZOOM Meeting link is:
UPCOMING MEETING: Tuesday, 14 June 2022 from 6:30 to 8:30 p.m.
REGISTRATION IS REQUIRED - PLEASE REGISTER AT: Click here. Note: If you do not have access to a computer you can also register by calling 703-698-2526 or 202-746-3045.
Dr. Korn joined Caris Life Sciences in September 2017 as Chief Medical Officer. In this role, Dr. Korn guides Caris’ research efforts and clinical strategies for innovative precision medicine tools and tumor profiling services. His executive oversight
responsibilities include medical affairs, evidence curation and collaborative research projects, in particular with the Caris Precision Oncology Alliance. This work has resulted in publication of over 175 posters/presentations at major medical conferences and 129 peer-reviewed publications since fall 2017.
Dr. Korn has an extensive career in cancer research and clinical oncology. He has long-standing research experience in comprehensive molecular tumor profiling and integration of these techniques in clinical practice. He has authored more than
75 peer-reviewed publications and his research on signal transduction and systems biology of cancer has been funded by the NIH and DoD since 2003. Dr. Korn served on the Esophago-Gastric Task Force of the NCI GI Steering Committee and the
National Comprehensive Cancer Network (NCCN) Esophageal and Gastric Cancer Panel until 2017.
Dr. Korn is also Professor Emeritus of Medicine and a gastrointestinal oncologist in the Division of Hematology/Oncology at the University of California, San Francisco (UCSF). He founded the Molecular Oncology Initiative at UCSF’s Helen Diller Family Comprehensive Cancer Center (HDFCCC), and initiated and chaired the UCSF Molecular Tumor Board, which is a cross-disciplinary platform supporting clinical decision making based on Next-Generation Sequencing results.
Us TOO Sterling offers men diagnosed with prostate cancer and their significant others an opportunity to get together in an informative, educational and supportive setting. After each month's presentation we have a question and answer session, and then a Caring & Sharing session, where we provide an opportunity to network with others who have had similar experiences. Spouses and significant others are encouraged to attend.